top of page


Lempo first priority is to advance its treatment to the market as fast as can be done and as safe as possible. 

For that reason, we feel fortunate and proud to be working with the following partners:

tau sacler logo

Looking to accelerate our pace and broaden our market reach we are constantly on the look for additional opportunities to cooperate in research, development and commercialization, both for the PAH and AAGN treatments as well as for additional indications, especially Multiple Sclerosis and Alzheimer's Disease.

To learn more about partnership opportunities with Lempo Therapeutics, please email us at

bottom of page